Quantcast
Last updated on April 16, 2014 at 5:31 EDT

Latest Angioplasty Stories

2013-06-11 12:28:17

- Trial to Study the Innovative "Dissolving" Heart Device Compared to Abbott's Market-Leading Drug Eluting Stents in Patients with Coronary Artery Disease in Japan ABBOTT PARK, Ill., June 11, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has initiated the ABSORB Japan randomized controlled clinical trial to evaluate the Absorb(TM) Bioresorbable Vascular Scaffold (BVS) in patients with coronary artery disease (CAD), the most common form of heart disease.(1) The...

2013-05-20 23:19:09

Allegheny General Hospital (AGH) in Pittsburgh has been selected to join the ABSORB III clinical trial, a multi-center international study exploring a unique bioresorbable vascular scaffold (BVS), a small mesh tube that is designed to open a blocked artery and then fully dissolve over time, leaving the vessel free of a permanent metallic implant. The FDA-approved study of the drug-eluting AbsorbTM BVS, made by healthcare company Abbott, is expected to enroll approximately 2,250 patients...

2013-05-08 11:55:21

Research suggests new reporting protocol for 30-day mortality for percutaneous coronary intervention to better reflect quality, performance Only 42 percent of the deaths occurring within 30 days of percutaneous coronary interventions (PCI) were attributable to complications from the procedure, according to a Cleveland Clinic study published online in the Journal of the American College of Cardiology. The research suggests alternative outcome reporting mechanisms for 30-day mortality for...

2013-05-06 23:25:38

Sanford Heart Hospital offers new minimally invasive technique Sioux Falls, SD (PRWEB) May 06, 2013 Patients suffering from severely clogged arteries known as coronary chronic total occlusions (CTO) now have a minimally invasive option as opposed to the traditional open heart bypass surgery. Sanford Heart Hospital in Sioux Falls has introduced the BridgePoint chronic total occlusion system for treatment of CTO's, which prevent blood circulation to the heart. The new technology offers a...

2013-05-03 12:25:24

HUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, today announced the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Dr. Gregg Stone, the principle investigator, presented the exciting findings at the 62(nd) Annual American College of Cardiology Conference in San Francisco, CA. INFUSE-AMI's primary endpoint was reduction in infarct size (also...

2013-05-01 15:35:57

In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens arteries blocked by clots or plaque deposits. After about six months, most damaged arteries are healed and stay open on their own. The stent, however, is there for a lifetime. Most of the time, that´s not a problem, says Patrick Bowen, a doctoral student studying materials science and...

2013-04-26 09:59:12

Novel treatment has potential in multiple cardiovascular diseases Up to 10 per cent of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascular events, including heart attacks. Clinical trials show that catheter-based renal denervation reduces blood pressure in patients who do not respond to conventional drug therapy. Use of the technique is increasing in Europe and worldwide and several national societies have published guidance...

2013-04-23 10:10:40

Researchers at the Stanford University School of Medicine have developed a method of predicting which patients with heart disease would benefit more from surgery and which would benefit more from angioplasty. Drawing on Medicare records of more than 100,000 patients with heart disease, the team demonstrated that the effectiveness of coronary bypass surgery varied widely based on each individual's characteristics. The data enabled them to predict which type of intervention – coronary...

2013-04-18 16:26:54

Scott C. Goodwin, M.D., FSIR, Begins Term as SIR President; New Executive Council Members Named During SIR's 38th Annual Scientific Meeting in New Orleans NEW ORLEANS, April 18, 2013 /PRNewswire-USNewswire/ -- Scott C. Goodwin, M.D., FSIR, an interventional radiologist and Hasso Brothers professor and chair of the department of radiological sciences at the University of California, Irvine, assumed office as the 2013-14 president of the Society of Interventional Radiology during SIR's...

2013-04-16 16:23:13

FARMINGTON, Mich., April 16, 2013 /PRNewswire/ -- Dr. Mark Rasak, MD is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates. Dr. Rasak has over 15 years of experience and specializes in managing all major aspects of the business; overseeing the daily operations; interventional cardiology; complex coronary angioplasty; as well as primary coronary intervention. In addition, he is an honored...


Latest Angioplasty Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »